國家衛生研究院 NHRI:Item 3990099045/11218
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 912341      線上人數 : 1162
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11218


    題名: Cross-presentation of lipidated and non-lipidated synthetic peptide
    作者: Liu, SJ;Shen, KY
    貢獻者: National Institute of Infectious Diseases and Vaccinology
    摘要: Cross-presentation is a key function of dendritic cells (DCs), which present exogenous antigens on MHC class I molecules to prime cytotoxic T lymphocyte (CTL) responses. Here, we used synthetic mono-, di-palmitoylated peptides and non-lipidated peptide that contain CTL epitopes of HPV E7. We observed that all three peptides can be internalized by the bone marrow-derived DCs (BMDCs) but using different pathway. The mono-palmitoylated peptide can be internalized by an energyindependent pathway. The di-palmitoylated peptides internalization was facilitated by TLR2 via clathrin-mediated endocytosis. The mono-palmitoylated peptide immunization can induce T cell responses and the anti-tumor effects can be enhanced in the presence of the emulsion type adjuvant. However, the administration of di-palmitoylated peptide alone can induce anti-tumor effects through TLR2. We further demonstrated that the induction of antigen-specific CTL responses and tumor regression by dipalmitoylated peptides was transporter associated with antigen processing (TAP) independent. In addition, presentation of di-palmitoylated peptides by MHC class I molecules was blocked in the presence of an endosomal acidification inhibitor (chloroquine) or a lysosomal degradation inhibitor (Z-FL-COCHO). In summary, our data suggest that the different types of the lapidated can have different mechanisms to induce anti-tumor effects.
    日期: 2018-05
    關聯: European Journal of Immunology. 2018 May;48(Suppl. 1):36.
    Link to: https://doi.org/10.1002/eji.201871000
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0014-2980&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000434106700051
    顯示於類別:[劉士任] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000434106700051.pdf225KbAdobe PDF287檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋